PURPOSE: Urolithiasis is a common disease with multiple etiologies and risk factors. Studies suggest an increased incidence in developed nations in recent decades as well as differential geographic incidence and prevalence rates, and differences between the genders. We updated urolithiasis epidemiological data by examining the incidence and prevalence rates in a stable rural Wisconsin population. MATERIALS AND METHODS: Data were obtained from the Marshfield Epidemiologic Study Area database, a surveillance tool created in 1991 to track disease in residents of an area of 24 ZIP Codes including approximately 85,000 individuals, of whom most receive care at Marshfield Clinic and affiliates. Urolithiasis cases were identified using ICD-9 codes. Incidence, prevalence and recurrence rates were determined. RESULTS: The mean age adjusted incidence of new onset urolithiasis per 100,000 person-years was 202 (95% CL 168-235) in 1992 and 289 (95% CL 253-325) in 2008. In women the increase per 100,000 person-years was higher than in men, that is 171 (95% CL 129-213) and 289 (95% CL 238-340) vs 238 (95% CL 184-290) and 296 (95% CL 244-348), respectively. The male-to-female incidence ratio decreased from 1.4 to 1.0. The age adjusted prevalence per 100,000 individuals was 1,968 (2%) and 3,554 (3.5%) in 1992 and 2008, respectively. The increase in women was higher than in men (52% vs 26%). The age adjusted recurrence rate per 100,000 individuals was 553 (0.72%) and 676 (1.0%) in 1992 and 2008, respectively. The increase in women was higher than in men (88% vs 20%). CONCLUSIONS: Since 1992, urolithiasis incidence, prevalence and recurrence rates in this rural Wisconsin population have increased with higher increases noted in women. While prevalence increased, it was lower than reported in other geographic areas in the United States.
PURPOSE:Urolithiasis is a common disease with multiple etiologies and risk factors. Studies suggest an increased incidence in developed nations in recent decades as well as differential geographic incidence and prevalence rates, and differences between the genders. We updated urolithiasis epidemiological data by examining the incidence and prevalence rates in a stable rural Wisconsin population. MATERIALS AND METHODS: Data were obtained from the Marshfield Epidemiologic Study Area database, a surveillance tool created in 1991 to track disease in residents of an area of 24 ZIP Codes including approximately 85,000 individuals, of whom most receive care at Marshfield Clinic and affiliates. Urolithiasis cases were identified using ICD-9 codes. Incidence, prevalence and recurrence rates were determined. RESULTS: The mean age adjusted incidence of new onset urolithiasis per 100,000 person-years was 202 (95% CL 168-235) in 1992 and 289 (95% CL 253-325) in 2008. In women the increase per 100,000 person-years was higher than in men, that is 171 (95% CL 129-213) and 289 (95% CL 238-340) vs 238 (95% CL 184-290) and 296 (95% CL 244-348), respectively. The male-to-female incidence ratio decreased from 1.4 to 1.0. The age adjusted prevalence per 100,000 individuals was 1,968 (2%) and 3,554 (3.5%) in 1992 and 2008, respectively. The increase in women was higher than in men (52% vs 26%). The age adjusted recurrence rate per 100,000 individuals was 553 (0.72%) and 676 (1.0%) in 1992 and 2008, respectively. The increase in women was higher than in men (88% vs 20%). CONCLUSIONS: Since 1992, urolithiasis incidence, prevalence and recurrence rates in this rural Wisconsin population have increased with higher increases noted in women. While prevalence increased, it was lower than reported in other geographic areas in the United States.
Authors: F DeStefano; E D Eaker; S K Broste; D L Nordstrom; P L Peissig; R A Vierkant; K A Konitzer; R L Gruber; P M Layde Journal: J Clin Epidemiol Date: 1996-06 Impact factor: 6.437
Authors: Charles D Scales; Lesley H Curtis; Regina D Norris; W Patrick Springhart; Roger L Sur; Kevin A Schulman; Glenn M Preminger Journal: J Urol Date: 2007-03 Impact factor: 7.450
Authors: J C Lieske; L S Peña de la Vega; J M Slezak; E J Bergstralh; C L Leibson; K-L Ho; M T Gettman Journal: Kidney Int Date: 2006-02 Impact factor: 10.612
Authors: Adam O Kadlec; Samuel Ohlander; James Hotaling; Jessica Hannick; Craig Niederberger; Thomas M Turk Journal: Urolithiasis Date: 2014-04-02 Impact factor: 3.436
Authors: Amy E Krambeck; John C Lieske; Xujian Li; Eric J Bergstralh; L Joseph Melton; Andrew D Rule Journal: J Urol Date: 2012-11-16 Impact factor: 7.450
Authors: Naeem Bhojani; Jennifer Bjazevic; Brendan Wallace; Linda Lee; Kamaljot S Kaler; Marie Dion; Andrea Cowan; Nabil Sultan; Ben H Chew; Hassan Razvi Journal: Can Urol Assoc J Date: 2022-06 Impact factor: 2.052
Authors: Wonngarm Kittanamongkolchai; Lisa E Vaughan; Felicity T Enders; Tsering Dhondup; Ramila A Mehta; Amy E Krambeck; Cynthia H McCollough; Terri J Vrtiska; John C Lieske; Andrew D Rule Journal: Mayo Clin Proc Date: 2018-02-14 Impact factor: 7.616
Authors: Charat Thongprayoon; Lisa E Vaughan; Api Chewcharat; Andrea G Kattah; Felicity T Enders; Rajiv Kumar; John C Lieske; Vernon M Pais; Vesna D Garovic; Andrew D Rule Journal: Am J Kidney Dis Date: 2021-04-15 Impact factor: 11.072